The World Will Be 100 Million Cancer Workers Short by 2050 – And No Region Will Be Spared

The world is heading toward a cancer care crisis. By 2050, nearly 100 million additional cancer workers will be needed to keep pace with rising cases – and the largest gaps will be among nurses, radiologists, and pathologists. Africa and Asia will be hit hardest, but no region will be spared.

A new report published by The Lancet Oncology Commission and presented at the 2026 American Society of Clinical Oncology annual meeting warns that a shortage of well-trained personnel to deliver cancer care and conduct research remains a major obstacle to reducing global disparities. Based on current trends, the study projects a shortage of 99.9 million cancer workers by 2050. This includes individuals involved in research, regulatory and financial support systems, and the communities that benefit from and contribute to research.

The deficits will be especially acute in Africa and Asia, with 34.3 million and 57.3 million workers missing, respectively. In low- and middle-income countries, scarcity is largely driven by brain drain – the migration of skilled workers abroad. In high-income countries, health systems are strained due to burnout, depression, and budget cuts.

By type of worker, the most affected will be primary and generalist care: more than 65 million additional nurses will be needed by 2050, alongside 16 million extra diagnostic specialists in radiology and pathology.

"Our global initiative brings a clear warning: without urgent action to address critical workforce shortages, we risk a cancer crisis unlike anything we've seen before," said the Commission's co-lead, Dr. Hedvig Hricak of Memorial Sloan Kettering Cancer Center in New York. "We call for immediate, country-specific strategies, smarter workforce use, task-shifting and AI/digital health adoption, alongside future-ready education and strong, sustainable financing through public–private partnerships."

Workforce shortages not only delay care for current patients but also hinder future research. "Advances in cancer research globally require a workforce that can generate ideas, design studies, lead teams and translate findings into robust cancer control practices and policies," the authors wrote.

Cancer cases are rising worldwide. The authors describe cancer as a silent pandemic. Cases are estimated to reach 35.3 million in 2050 – up from 20 million in 2022 – with 18.5 million deaths projected each year. Approximately 70% of newly diagnosed cancer cases will occur in low- and middle-income countries – the same regions that will suffer most from workforce shortages.

The researchers used the Global Cancer Workforce microsimulation model, which accounts for demographic, epidemiological, and health system factors related to cancer incidence and survival. They modeled the current and future global landscape of 17 common cancers and 18 workforce personnel types in 200 countries and territories from 2030 to 2050.

"These findings are sobering; the predicted 35 million rise in cancer cases each year globally is in sharp contrast to the projected global shortfall of 100 million cancer care workers by 2050," said Mark Lawler from Queen's University Belfast, a co-author of the study. "Make no mistake; this is a wake-up call, no matter where you are in the world. What we've uncovered is shocking – how can we reconcile a 15 million increase in cancer cases diagnosed with a 100 million decrease in cancer staffing? The data, unfortunately, does not lie. We can't wait until 2050 to see if our projections are correct – we must act now."

Across all cancer types included in the model, the global diagnosed incidence rate is projected to rise from 165 per 100,000 people in 2025 to 200 per 100,000 in 2050. Increases are expected across all geographic regions and cancer types, with the exception of stomach cancer. Lung, breast, colorectal, and prostate cancers are projected to remain the most commonly diagnosed cancers globally.

"Understanding trends in cancer incidence, survival, and workforce – and how they vary by context or geography – is essential for effective cancer control planning and resource allocation," the authors wrote.

For now, the numbers are clear. Cancer is rising. The workforce is not. And the gap – 100 million workers – is so large that no single country can fill it alone. The Lancet report is not a prediction. It is a warning. And the clock is already ticking.

Written by Martina Kirchner